Search research articles
Contact Us
Filters
Showing results (1-10 of 29) with videos related to
Page
of 3
Sort By:
Trends in Cancer
|
May 11, 2020
Amyloid Evolvability and Cancer
Yoshiki Takamatsu, Gilbert Ho, Makoto Hashimoto
Prion
|
February 14, 2023
Differential involvement of amyloidogenic evolvability in oligodendropathies; Multiple Sclerosis and Multiple System Atrophy
Jianshe Wei, Gilbert Ho, Eliezer Masliah, et al.
Parkinson'S Disease
|
December 3, 2021
Therapeutic Potential of <i>α</i>-Synuclein Evolvability for Autosomal Recessive Parkinson's Disease
Jianshe Wei, Gilbert Ho, Yoshiki Takamatsu, et al.
Frontiers in Cell and Developmental Biology
|
July 29, 2024
Innate neuroimmunity across aging and neurodegeneration: a perspective from amyloidogenic evolvability
Gilbert Ho, Linh Lam, Tony Tran, et al.
Neoplasia (New York, N.Y.)
|
December 14, 2020
Adiponectin paradox as a therapeutic target of the cancer evolvability in aging
Yoshiki Takamatsu, Gilbert Ho, Ryoko Wada, et al.
International Journal of Molecular Sciences
|
April 25, 2020
Possible Role of Amyloidogenic Evolvability in Dementia with Lewy Bodies: Insights from Transgenic Mice Expressing P123H β-Synuclein
Masayo Fujita, Gilbert Ho, Yoshiki Takamatsu, et al.
Drug Discovery Today
|
March 29, 2021
Diabetes, inflammation, and the adiponectin paradox: Therapeutic targets in SARS-CoV-2
Gilbert Ho, Alysha Ali, Yoshiki Takamatsu, et al.
Journal of Neurochemistry
|
August 10, 2006
Effects of the cholesterol-lowering compound methyl-beta-cyclodextrin in models of alpha-synucleinopathy
Pazit Bar-On, Edward Rockenstein, Anthony Adame, et al.
Journal of Alzheimer'S Disease Reports
|
May 20, 2022
Reconsideration of Alzheimer's Disease Therapy from a Viewpoint of Amyloidogenic Evolvability
Gilbert Ho, Pei Chen Choo, Masaaki Waragai, et al.
Biomolecules
|
March 6, 2021
Therapeutic Potential of αS Evolvability for Neuropathic Gaucher Disease
Jianshe Wei, Yoshiki Takamatsu, Ryoko Wada, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 29) with videos related to
Sort By:
Page
of 3
Trends in Cancer
|
May 11, 2020
Amyloid Evolvability and Cancer
Yoshiki Takamatsu, Gilbert Ho, Makoto Hashimoto
Prion
|
February 14, 2023
Differential involvement of amyloidogenic evolvability in oligodendropathies; Multiple Sclerosis and Multiple System Atrophy
Jianshe Wei, Gilbert Ho, Eliezer Masliah, et al.
Parkinson'S Disease
|
December 3, 2021
Therapeutic Potential of <i>α</i>-Synuclein Evolvability for Autosomal Recessive Parkinson's Disease
Jianshe Wei, Gilbert Ho, Yoshiki Takamatsu, et al.
Frontiers in Cell and Developmental Biology
|
July 29, 2024
Innate neuroimmunity across aging and neurodegeneration: a perspective from amyloidogenic evolvability
Gilbert Ho, Linh Lam, Tony Tran, et al.
Neoplasia (New York, N.Y.)
|
December 14, 2020
Adiponectin paradox as a therapeutic target of the cancer evolvability in aging
Yoshiki Takamatsu, Gilbert Ho, Ryoko Wada, et al.
International Journal of Molecular Sciences
|
April 25, 2020
Possible Role of Amyloidogenic Evolvability in Dementia with Lewy Bodies: Insights from Transgenic Mice Expressing P123H β-Synuclein
Masayo Fujita, Gilbert Ho, Yoshiki Takamatsu, et al.
Drug Discovery Today
|
March 29, 2021
Diabetes, inflammation, and the adiponectin paradox: Therapeutic targets in SARS-CoV-2
Gilbert Ho, Alysha Ali, Yoshiki Takamatsu, et al.
Journal of Neurochemistry
|
August 10, 2006
Effects of the cholesterol-lowering compound methyl-beta-cyclodextrin in models of alpha-synucleinopathy
Pazit Bar-On, Edward Rockenstein, Anthony Adame, et al.
Journal of Alzheimer'S Disease Reports
|
May 20, 2022
Reconsideration of Alzheimer's Disease Therapy from a Viewpoint of Amyloidogenic Evolvability
Gilbert Ho, Pei Chen Choo, Masaaki Waragai, et al.
Biomolecules
|
March 6, 2021
Therapeutic Potential of αS Evolvability for Neuropathic Gaucher Disease
Jianshe Wei, Yoshiki Takamatsu, Ryoko Wada, et al.
Page
of 3